Release Date: 16/07/12 14:28 Summary: Boardroom Radio Interview Price Sensitive: No Download Document 327.52KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%